The Knowledge Within: An Interview With Merck KGaA’s R&D Chief
The Knowledge Within: An Interview With Merck KGaA’s R&D Chief
$200.00
Merck KGaA’s head of global research and development, Luciano Rossetti, sat down with In Vivo to discuss the track the German company is taking toward becoming a major player in global immuno-oncology. Tap in to his insights and opinions in this essential interview.
Author: Lucie Ellie
Publisher: InVivo
- Description
Merck KGaA seems poised to take off in the immuno-oncology realm, with several key drugs moving through its pipeline and the launch of a promising IO partnership with GlaxoSmithKline to develop and market its M7824 (bintrafusp alfa*) investigational immunotherapy. Get an inside look at key developments at Merck with this In Vivo interview with Luciano Rossetti, the company’s head of global research and development, as Rossetti discusses Merck’s immuno-oncology innovations, the GSK IO alliance, and how it all fits into the larger landscape for cancer drug development.
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
House Committee Hearing Shows How Talc/Asbestos Concerns Could Be Impetus For... 
Sign up to the